MD
Price
$16.59
Change
+$0.41 (+2.53%)
Updated
Sep 18 closing price
Capitalization
1.44B
41 days until earnings call
THC
Price
$190.21
Change
+$6.74 (+3.67%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
16.81B
27 days until earnings call
Interact to see
Advertisement

MD vs THC

Header iconMD vs THC Comparison
Open Charts MD vs THCBanner chart's image
Pediatrix Medical Group
Price$16.59
Change+$0.41 (+2.53%)
Volume$754.12K
Capitalization1.44B
Tenet Healthcare
Price$190.21
Change+$6.74 (+3.67%)
Volume$6.57K
Capitalization16.81B
MD vs THC Comparison Chart in %
Loading...
MD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MD vs. THC commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MD is a Hold and THC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (MD: $16.59 vs. THC: $190.29)
Brand notoriety: MD and THC are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: MD: 96% vs. THC: 86%
Market capitalization -- MD: $1.44B vs. THC: $16.81B
MD [@Hospital/Nursing Management] is valued at $1.44B. THC’s [@Hospital/Nursing Management] market capitalization is $16.81B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $93.85B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MD’s FA Score shows that 1 FA rating(s) are green whileTHC’s FA Score has 3 green FA rating(s).

  • MD’s FA Score: 1 green, 4 red.
  • THC’s FA Score: 3 green, 2 red.
According to our system of comparison, THC is a better buy in the long-term than MD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MD’s TA Score shows that 6 TA indicator(s) are bullish while THC’s TA Score has 5 bullish TA indicator(s).

  • MD’s TA Score: 6 bullish, 4 bearish.
  • THC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MD is a better buy in the short-term than THC.

Price Growth

MD (@Hospital/Nursing Management) experienced а -2.47% price change this week, while THC (@Hospital/Nursing Management) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.85%. For the same industry, the average monthly price growth was +119.40%, and the average quarterly price growth was +85.59%.

Reported Earning Dates

MD is expected to report earnings on Oct 30, 2025.

THC is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Hospital/Nursing Management (-0.85% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THC($16.8B) has a higher market cap than MD($1.45B). MD has higher P/E ratio than THC: MD (12.76) vs THC (11.96). THC YTD gains are higher at: 50.749 vs. MD (26.448). THC has higher annual earnings (EBITDA): 4.62B vs. MD (204M). THC has more cash in the bank: 2.63B vs. MD (348M). MD has less debt than THC: MD (650M) vs THC (13.2B). THC has higher revenues than MD: THC (20.7B) vs MD (1.94B).
MDTHCMD / THC
Capitalization1.45B16.8B9%
EBITDA204M4.62B4%
Gain YTD26.44850.74952%
P/E Ratio12.7611.96107%
Revenue1.94B20.7B9%
Total Cash348M2.63B13%
Total Debt650M13.2B5%
FUNDAMENTALS RATINGS
MD vs THC: Fundamental Ratings
MD
THC
OUTLOOK RATING
1..100
6678
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
10013
SMR RATING
1..100
5623
PRICE GROWTH RATING
1..100
4545
P/E GROWTH RATING
1..100
259
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MD's Valuation (56) in the Medical Or Nursing Services industry is in the same range as THC (60) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to THC’s over the last 12 months.

THC's Profit vs Risk Rating (13) in the Hospital Or Nursing Management industry is significantly better than the same rating for MD (100) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than MD’s over the last 12 months.

THC's SMR Rating (23) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MD (56) in the Medical Or Nursing Services industry. This means that THC’s stock grew somewhat faster than MD’s over the last 12 months.

THC's Price Growth Rating (45) in the Hospital Or Nursing Management industry is in the same range as MD (45) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to MD’s over the last 12 months.

THC's P/E Growth Rating (9) in the Hospital Or Nursing Management industry is in the same range as MD (25) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to MD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDTHC
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
68%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVQX16.28N/A
N/A
Lord Abbett Fundamental Equity R2
ECFVX19.84N/A
N/A
Eaton Vance Focused Value Opps C
IMOWX26.72N/A
N/A
Voya MidCap Opportunities W
ACWIX19.22N/A
N/A
AMG GW&K Small/Mid Cap Growth I
FTGQX29.80N/A
N/A
Templeton Growth C